The effects of trimetazidine on P-wave duration and dispersion in heart failure patients

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 2, 2009, Pages 239-244

  Gunes, Yilmaz ^a   Tuncer, Mustafa ^a   Guntekin, Unal ^a   Akdag, Serkan ^a   Gumrukcuoglu, Hasan Ali ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Heart failure; P wave dispersion; Trimetazidine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; INOTROPIC AGENT; SPIRONOLACTONE; TRIMETAZIDINE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; P WAVE; RELAXATION TIME;

CHEMOTHERAPY, ADJUVANT; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TRIMETAZIDINE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 58849084581     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.02208.x     Document Type: Article

References (27)

1. Roithinger FX, Karch MR, Steiner PR, Sippens GA, Lesh MD. The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerability. J Interv Card Electrophysiol 1999 3 : 311 319.
2. Michelucci A, Giuseppe B, Colella A, Pieragnoli P, Porciani MC, Gensini G, Padeletti L. P wave assessment: Statement of the art update. Card Electrophys Rev 2002 6 : 215 220.
3. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: Natural history, complications and management. Ann Rev Med 1988 39 : 41 52.
4. Senen K, Turhan H, Erbay A, Basar N, Yasar AS, Sahin O, Yetkin E. P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail 2004 6 : 567 569.
5. Lopaschuk GD, Stanley WA, Lopaschuk CC. Metabolic approach in heart failure: The rationale for metabolic interventions. Heart Metab 2005 27 : 5 10.
6. Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor in patients with heart failure. J Am Coll Cardiol 2006 48 : 992 998.
7. Sisakian H, Torgomyan A, Barkhudaryan A. The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy. Acta Cardiol 2007 62 : 493 499.
8. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: Potential for therapeutic interventions. Heart Fail Rev 2002 7 : 115 130.
9. Brottier L, Barat JL, Combe C, Boussens B, Bonnet J, Bricaud H. Therapeutic value of a cardio protective agent in patients with severe ischaemic cardiomyopathy. Eur Heart J 1990 11 : 207 212.
10. Di Napoli P, Taccardi AA, Barsotti A. Long term cardioprotective action of trimetazidine and potential effects on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart 2005 91 : 161 165.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiography 2005 18 : 1440 1463.
12. Dilaveris PE, Stefanadis CI. P wave dispersion: A valuable non-invasive marker of vulnerability to atrial arrhythmias. Hospital Chronicles 2006 1 : 130 137.
13. Camsari A, Pekdemir H, Akkus N, Yenihan S, Doven O, Cin VG. Long-term effects of beta blocker therapy on P-wave duration and dispersion in congestive heart failure patients: A new effect? J Electrocardiol 2003 36 : 111 116.
14. Song J, Kalus JS, Caron MF, Kluger J, White CM. Effect of diuresis on P wave duration and dispersion. Pharmacotherapy 2002 22 : 564 568.
15. Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM. Diastolic dysfunction and left atrial volume: A population-based study. J Am Coll Cardiol 2005 45 : 87 92.
16. Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio TA. Left atrial volume, geometry, and function in systolic and diastolic heart failure of persons 65 years of age (The Cardiovascular Health Study). Am J Cardiol 2006 97 : 83 89.
17. Gunduz H, Binak E, Arinc H, Akdemir R, Ozhan H, Tamer A, Uyan C. The Relationship between P wave dispersion and diastolic dysfunction. Tex Heart Inst J 2005 32 : 163 167.
18. Kim DH, Chang GC, Kim SH, Yu HK, Choi WG, An IS, Kwan J, et al. The relationship between the left atrial volume and the maximum P-wave and P-wave dispersion in patients with congestive heart failure. Yonsei Med J 2007 48 : 810 817.
19. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. Framingham Heart Study Circulation 1994 89 : 724 730.
20. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997 96 : 2455 2461.
21. Francis GS, McDonald KM, Cohn JN. Neurohumoral activation in preclinical heart failure. Circulation 1993 87 : 90 96.
22. Coumel P. Paroxysmal atrial fibrillation: A disorder of autonomic tone? Eur Heart J 1994 15 : 9 16.
23. Tukek T, Akkaya V, Demirel S, Sözen AB, Kudat H, Atilgan D, Ozcan M, et al. Effect of valsalva maneuver on surface electrocardiographic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 2000 85 : 896 899.
24. Ulgen MS, Akdemir O, Toprak N. The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarction. Int J Cardiol 2001 77 : 255 262.
25. Guler N, Eryonucu B, Gunes A, Guntekin U, Tuncer M, Ozbek H. Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction. Cardiovasc Drugs Ther 2003 17 : 371 374.
26. Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, Oto A, et al. P wave dispersion on 12 lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000 23 : 1109 1012.
27. Dilaveris PE, Gialafos JE. P-wave duration and dispersion analysis: methodological considerations. Circulation 2001 103 : E111 1.